The role of complement in Streptococcus pneumoniae-associated haemolytic uraemic syndrome

Nephrology Dialysis Transplantation

Volumn 28, Issue 9, 2013, Pages 2237-2245

  Szilágyi, Ágnes ^a   Kiss, Nóra ^a   Bereczki, Csaba ^b   Tálosi, Gyula ^b   Rácz, Katalin ^b   Túri, Sándor ^b   Györke, Zsuzsa ^c   Simon, Edina ^d   Horváth, Eszter ^d   Kelen, Kata ^a   Reusz, György S ^a   Szabó, Attila J ^a   Tulassay, Tivadar ^a   Prohászka, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d Petz Aladar Teaching Hospital   (Hungary)

Author keywords

Alternative pathway; Classical pathway; Complement; Haemolytic uraemic syndrome; Mutation; Streptococcus pneumoniae

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; FACTOR H AUTOANTIBODY; MEMBRANE COFACTOR PROTEIN; SIALIDASE; THROMBOMODULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; C3 GENE; CHILD; CLINICAL ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT FACTOR B GENE; COMPLEMENT FACTOR H GENE; COMPLEMENT FACTOR I GENE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME BLOOD LEVEL; FEMALE; GENE; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HEMOLYTIC UREMIC SYNDROME; HUMAN; MEMBRANE COFACTOR PROTEIN GENE; MOLECULAR PATHOLOGY; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; REMISSION; SCHOOL CHILD; THROMBOMODULIN GENE;

ALTERNATIVE PATHWAY; CLASSICAL PATHWAY; COMPLEMENT, MUTATION; HAEMOLYTIC URAEMIC SYNDROME; STREPTOCOCCUS PNEUMONIAE;

ADAM PROTEINS; CHILD, PRESCHOOL; COMPLEMENT SYSTEM PROTEINS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MUTATION; NEURAMINIDASE; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 84884526601     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft198     Document Type: Article

References (40)

1. Caprioli J, Remuzzi G, Noris M. Thrombotic microangiopathies: from animal models to human disease and cure. Contrib Nephrol 2011; 169: 337-350
2. Karpman D, Sartz L, Johnson S. Pathophysiology of typical hemolytic uremic syndrome. Semin Thromb Hemost 2010; 36: 575-585
3. Loirat C, Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 2011; 6: 60
4. Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome: classification and the emergence of serotype 19A. Pediatrics 2010; 125: e174-e182
5. Allen U, Licht C. Pandemic H1N1 influenza A infection and (atypical) HUS-more than just another trigger? Pediatr Nephrol 2011; 26: 3-5
6. Besbas N, Karpman D, Landau D et al. A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney Int 2006; 70: 423-431
7. Copelovitch L, Kaplan BS. Streptococcus pneumoniae-associated hemolytic uremic syndrome. Pediatr Nephrol 2008; 23: 1951-1956
8. Klein PJ, Bulla M, Newman RA et al. Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome. Lancet 1977; 2: 1024-1025
9. Mulder AH, Gerlag PG, Verhoef LH et al. Hemolytic uremic syndrome after capnocytophaga canimorsus (DF-2) septicemia. Clin Nephrol 2001; 55: 167-170
10. Tobe TJ, Franssen CF, Zijlstra JG et al. Hemolytic uremic syndrome due to Capnocytophaga canimorsus bacteremia after a dog bite. Am J Kidney Dis 1999; 33: e5
11. Huang DT, Chi H, Lee HC et al. T-antigen activation for prediction of pneumococcus-induced hemolytic uremic syndrome and hemolytic anemia. Pediatr Infect Dis J 2006; 25: 608-610
12. Seelen MA, Roos A, Wieslander J et al. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 2005; 296: 187-198
13. Reti M, Farkas P, Csuka D et al. Complement activation in thrombotic thrombocytopenic purpura. J Thromb Haemost 2012; 10: 791-798
14. Potier M, Mameli L, Belisle M et al. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-DN-acetylneuraminate) substrate. Anal Biochem 1979; 94: 287-296
15. Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7: 248-249
16. Choi Y, Sims GE, Murphy S et al. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012; 7: e46688
17. Schwarz JM, Rodelsperger C, Schuelke M et al. Mutation Taster evaluates disease-causing potential of sequence alterations. Nat Methods 2010; 7: 575-576
18. Barrett JC, Fry B, Maller J et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265
19. Case definitions for infectious conditions under public health surveillance. Centers for disease control and prevention. MMWR Recomm Rep 1997; 46: 1-55
20. Bienaime F, Dragon-Durey MA, Regnier CH et al. Mutations in components of complement influence the outcome of Factor Iassociated atypical hemolytic uremic syndrome. Kidney Int 2010; 77: 339-349
21. Fremeaux-Bacchi V, Kemp EJ, Goodship JA et al. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet 2005; 42: 852-856
22. Caprioli J, Castelletti F, Bucchioni S et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum Mol Genet 2003; 12: 3385-3395
23. Esparza-Gordillo J, Goicoechea de Jorge E, Buil A et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum Mol Genet 2005; 14: 703-712
24. Brittan JL, Buckeridge TJ, Finn A et al. Pneumococcal neuraminidase A: an essential upper airway colonization factor for Streptococcus pneumoniae. Mol Oral Microbiol 2012; 27: 270-283
25. Pettigrew MM, Fennie KP, York MP et al. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun 2006; 74: 3360-3365
26. Hanisch FG, Baldus SE. The Thomsen-Friedenreich (TF) antigen: a critical review on the structural, biosynthetic and histochemical aspects of a pancarcinoma-associated antigen. Histol Histopathol 1997; 12: 263-281
27. Coats MT, Murphy T, Paton JC et al. Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase A. Microb Pathog 2011; 50: 343-349
28. Hofer J, Janecke AR, Zimmerhackl LB et al. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. Clin J Am Soc Nephrol 2013; 8: 407-15
29. Delvaeye M, Noris M, De Vriese A et al. Thrombomodulin mutations in atypical hemolytic-uremic syndrome. N Engl J Med 2009; 361: 345-357
30. Prohaszka Z, Varga L, Fust G. The use of 'real-time' complement analysis to differentiate atypical haemolytic uraemic syndrome from other forms of thrombotic microangiopathies. Br J Haematol 2012; 158: 424-425
31. Johnson S, Waters A. Is complement a culprit in infectioninduced forms of haemolytic uraemic syndrome? Immunobiology 2012; 217:235-243
32. Coonrod JD, Rylko-Bauer B. Complement levels in pneumococcal pneumonia. Infect Immun 1977; 18: 14-22
33. Reed WP, Davidson MS, Williams RC, Jr. Complement system in pneumococcal infections. Infect Immun 1976; 13: 1120-1125
34. Rabinovitch RA, Koethe SM, Kalbfleisch JH et al. Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection. J Clin Microbiol 1986; 23: 56-61
35. Ram S, Sharma AK, Simpson SD et al. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 1998; 187: 743-752
36. Pelras S, Delmas Y, Lamireau D et al. Severe transient ADAMTS13 deficiency in pneumococcal-associated hemolytic uremic syndrome. Pediatr Nephrol 2011; 26: 631-635
37. Banerjee R, Hersh AL, Newland J et al. Streptococcus pneumoniae- associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J 2011; 30: 736-739
38. Huang YH, Lin TY, Wong KS et al. Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan. Eur J Pediatr 2006; 165: 332-335
39. Prestidge C, Wong W. Ten years of pneumococcal-associated haemolytic uraemic syndrome in New Zealand children. J Paediatr Child Health 2009; 45: 731-735
40. Waters AM, Kerecuk L, Luk D et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United Kingdom experience. J Pediatr 2007; 151: 140-144